ResMed buys HME software vendor Jaysec


Wednesday, 11 February, 2015

ResMed (ASX:RMD) has announced the acquisition of Jaysec, a US-based provider of internet-based software for the home medical equipment (HME) industry.

Jaysec provides products to help HME providers resupply their patients and communicate with referring clinicians.

The company’s GoJaysec automated resupply offering uses interactive, voice, text and email communications to allow customers to authorise HME resupplies for equipment including CPAP masks and accessories - ResMed’s bread and butter.

ResMed has revealed plans to incorporate Jaysec software into its product line.

“Acquiring Jaysec furthers our commitment to helping HMEs drive business efficiencies while delivering positive patient outcomes. We’re excited to bring Jaysec into the ResMed fold, and we look forward to supporting existing and new customers alike,” ResMed President of Global Healthcare Informatics Raj Sodhi said.

ResMed separately revealed that it has entered an agreement to incorporate its AirView patient management system with Brightree’s HME billing and business management software.

ResMed and Brightree have been collaborating since 2013 to improve workflow efficiency, ease of use and business benefits for their joint customers.

“Directly integrating AirView into the industry-leading Brightree software platform underscores ResMed’s commitment to providing our HME customers with the tools they need, in the formats of their choosing, to help drive business efficiencies and optimal care,” Sodhi said.

ResMed (ASX:RMD) shares were trading 1.108% higher at $0.09 as of around 2 pm on Wednesday.

Related News

Immune cell boost could enable lasting vaccine protection

A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...

Genes influence when babies start walking

Genetics accounts for about a quarter of the differences in when children take their first steps,...

Novel glycopeptide antibiotic candidate shows promise

Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd